Log in to save to my catalogue

Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6539182

Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

About this item

Full title

Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2019-05, Vol.20 (9), p.2161

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Apolipoprotein E (apoE), a key lipid transport protein in the brain, is predominantly produced by astrocytes. Astrocytes are the most numerous cell type in the brain and are the main support network for neurons. They play a critical role in the synthesis and delivery of cholesterol in the brain. Humans have three common apoE isoforms, apoE2, apoE3...

Alternative Titles

Full title

Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6539182

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6539182

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms20092161

How to access this item